Antibodies to N‐terminal peptides of gonococcal porin are bactericidal when gonococcal lipopolysaccharide is not sialylated
- 1 September 1992
- journal article
- Published by Wiley in Molecular Microbiology
- Vol. 6 (18) , 2617-2628
- https://doi.org/10.1111/j.1365-2958.1992.tb01439.x
Abstract
Six synthetic 25-mer peptides corresponding to certain presumed surface-exposed regions of gonococcal porin protein I (PI) were made from strains FA19 (PIA) and MS11 (PIB). Four peptides were immunogenic in rabbits. Affinity-purified antisera against both PIA and PIB N-terminal peptides were bactericidal for homologous gonococci and many heterologous PI serovars. However, sialylation of gonococcal lipopolysaccharide (LPS) by growth of gonococci in the presence of cytidine monophosphate-neuraminic acid (CMP-NANA) abrogated the bactericidal activity of these antisera. Binding of anti-PI monoclonal antibodies to whole gonococci was reduced two- to fourfold by sialylation of LPS, suggesting that sialylation may inhibit bactericidal activity by masking porin epitopes. However, binding of anti-PII (Opa) monoclonal antibodies was not inhibited, yet complement-mediated killing was inhibited by sialylated LPS. Binding of complement components C3 and C9 was inhibited in the presence of either anti-PI or anti-PII monoclonals when gonococci were grown in the presence of CMP-NANA. Thus sialylation inhibited both anti-PI antibody binding and complement deposition, with a resultant decrease in bactericidal activity.Keywords
This publication has 59 references indexed in Scilit:
- Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetiiCellular Microbiology, 2007
- Gonococcal outer-membrane protein PIB: comparative sequence analysis and localization of epitopes which are recognized by type-specific and cross-reacting monoclonal antibodiesJournal of General Microbiology, 1990
- Construction of isogenic gonococci with variable porin structure: effects on susceptibility to human serum and antibioticsMolecular Microbiology, 1990
- Vaccination against gonorrhoea: the potential protective effect of immunization with a synthetic peptide containing a conserved epitope of gonococcal outer membrane protein IBVaccine, 1990
- In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation.The Journal of Experimental Medicine, 1990
- Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection.Journal of Clinical Investigation, 1989
- Topographical alterations in proteins I of Neisseria gonorrhoeae correlated with lipooligosaccharide variationMolecular Microbiology, 1989
- Serological Classification of Neisseria gonorrhoeae with Use of Monoclonal Antibodies to Gonococcal Outer Membrane Protein IThe Journal of Infectious Diseases, 1984
- Complement and Bacteria: Chemistry and Biology in Host DefenseAnnual Review of Immunology, 1984
- Solid Phase Peptide Synthesis. I. The Synthesis of a TetrapeptideJournal of the American Chemical Society, 1963